Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.080
-0.130 (-5.88%)
At close: Sep 8, 2026, 4:00 PM EDT
2.050
-0.030 (-1.44%)
After-hours: Sep 8, 2026, 7:39 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $89.33 million as of September 8, 2026. Its market cap has increased by 26.00% in one year.
Market Cap
89.33M
Enterprise Value
89.70M
1-Year Change
26.00%
Ranking
Category
Stock Price
$2.08
ChartMarket Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $89.33M, a decrease of -93.30%. That is a compound annual growth rate of -36.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 89.33M | -2.00% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MaxCyte | 132.10M |
| Apyx Medical | 128.48M |
| Quanterix | 127.22M |
| LENSAR | 105.41M |
| Microbot Medical | 96.72M |
| Hyperfine | 86.25M |
| electroCore | 83.04M |
| CVRx, Inc. | 81.26M |